Neuren Pharmaceuticals Ltd (NURPF)
13.56
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
Neuren Pharmaceuticals Total Liabilities (Quarterly): 29.13M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 29.13M |
| June 30, 2023 | 3.978M |
| December 31, 2022 | 1.142M |
| June 30, 2022 | 0.7539M |
| December 31, 2021 | 0.5821M |
| June 30, 2021 | 1.769M |
| December 31, 2020 | 0.579M |
| June 30, 2020 | 0.413M |
| December 31, 2019 | 0.3913M |
| June 30, 2019 | 0.9251M |
| December 31, 2018 | 1.390M |
| June 30, 2018 | 0.952M |
| December 31, 2017 | 1.232M |
| June 30, 2017 | 0.4342M |
| December 31, 2016 | 1.466M |
| June 30, 2016 | 1.231M |
| December 31, 2015 | 1.822M |
| June 30, 2015 | 2.596M |
| Date | Value |
|---|---|
| December 31, 2014 | 2.477M |
| June 30, 2014 | 2.311M |
| December 31, 2013 | 1.836M |
| June 30, 2013 | 2.078M |
| December 31, 2012 | 2.225M |
| June 30, 2012 | 2.632M |
| December 31, 2011 | 1.707M |
| June 30, 2011 | 1.649M |
| December 31, 2010 | 2.218M |
| June 30, 2010 | 1.891M |
| December 31, 2009 | 2.636M |
| June 30, 2009 | 2.631M |
| December 31, 2008 | 2.095M |
| June 30, 2008 | 2.056M |
| June 30, 2007 | 3.553M |
| June 30, 2006 | 1.962M |
| December 31, 2005 | 2.234M |
| June 30, 2005 | 2.357M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.3913M
Minimum
Dec 2019
29.13M
Maximum
Dec 2023
3.967M
Average
0.8395M
Median
Total Liabilities (Quarterly) Benchmarks
| Alterity Therapeutics Ltd | 2.345M |
| Kazia Therapeutics Ltd | 13.02M |
| Immutep Ltd | 9.137M |
| Opthea Ltd | 213.41M |
| Mesoblast Ltd | 167.58M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 168.94M |
| Shareholders Equity (Quarterly) | 139.81M |
| Current Ratio | 5.780 |